300404 博济医药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.5733.0512.9832.6883.316
总资产报酬率 ROA (%)0.9971.9801.9991.8072.302
投入资产回报率 ROIC (%)1.2352.4042.3352.0722.629

边际利润分析
销售毛利率 (%)28.45127.12530.37533.33637.932
营业利润率 (%)8.9413.6012.5053.1734.611
息税前利润/营业总收入 (%)9.0373.5732.6253.0955.596
净利润/营业总收入 (%)7.2993.7894.1324.8926.918

收益指标分析
经营活动净收益/利润总额(%)117.873153.067164.95697.999102.612
价值变动净收益/利润总额(%)6.5167.72016.49415.79715.275
营业外收支净额/利润总额(%)-0.024-4.081-0.908-0.05220.496

偿债能力分析
流动比率 (X)1.9241.8291.9632.2802.336
速动比率 (X)1.4741.3951.4861.7231.775
资产负债率 (%)34.06334.97430.94231.41029.769
带息债务/全部投入资本 (%)19.94921.51919.06922.01920.436
股东权益/带息债务 (%)397.478361.254419.210348.080379.442
股东权益/负债合计 (%)187.629179.912216.867212.970226.979
利息保障倍数 (X)91.99031.55618.448-40.563-27.485

营运能力分析
应收账款周转天数 (天)80.44074.02568.92266.68769.345
存货周转天数 (天)132.526118.722135.379178.493216.752